Strategies to Continue Gynae-oncology Services in the Era of COVID-19 Outbreak: Concerns and Challenges in a Referral Centre in Malaysia

A short survey involving 100 participants was conducted online to explore the understanding of Covid 19 pandemic impact and importance of vaccination among cancer survivors.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Covid19 Behavior COVID-19 Coronaviridae Infections Coronavirus Infections Health Behavior Infections Lung Diseases Nidovirales Infections Pneumonia Pneumonia, Viral RNA Virus Infections Respiratory Tract Diseases Respiratory Tract Infections Survivorship Treatment Adherence and Compliance Treatment Refusal Vaccination Refusal Virus Diseases

Sex eligibility

Female

Study type

Observational

Primary location

Dept O&G, UKM Medical Centre

Kuala Lumpur, 56000, Malaysia

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Female cancer survivors or care-taker undergoing national covid 19 vaccine -

Exclusion criteria

Male, not cancer survivors

Treatment and study plan

Primary outcomes

Vaccination refusal

Time frame: 8 months

Number of cancer survivors refuse vaccine
Reason for Refusal of Vaccine

Time frame: 8 months

Number of cancer survivors refuse vaccine

Sponsors and collaborators

Lead sponsor

Universiti Kebangsaan Malaysia Medical Centre

Other

Registry information

Important dates

Study start: 2021
Primary completion: 2021
Study completion: 2021
First posted: Sep 14, 2021
Registry last updated: Sep 14, 2021

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Active, Not Recruiting